Wellcome Trust Sanger Institute - Genome Research Limited

Wellcome Trust Sanger Institute, Genome Research Limited
Genome Research Limited
CB10 1SA
United Kingdom


Prof. Michael Stratton

principal investigator

Tel.: +44 122 349 47 57
Tel.2: +44 122 349 47 39

Personal website

Michael Stratton (MD, PhD) is Director of the Wellcome Trust Sanger Institute. He was leader of the group that mapped and identified the high risk breast cancer susceptibility gene, BRCA2. His research interests are in the genetics of cancer.

Jo Jones